FTC opens in­ves­ti­ga­tion in­to largest PBM­s' an­ti­com­pet­i­tive prac­tices

The Fed­er­al Trade Com­mis­sion is turn­ing up the heat on the drug in­dus­try’s mid­dle­men, launch­ing an in­ves­ti­ga­tion in­to phar­ma­cy ben­e­fit man­ag­er prac­tices and the ef­fect …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER